pyridinolcarbamate has been researched along with Angor Pectoris in 2 studies
Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atroshchenko, ES | 1 |
| Karpova, IS | 1 |
| Gulyás, A | 1 |
| Szám, I | 1 |
2 other studies available for pyridinolcarbamate and Angor Pectoris
| Article | Year |
|---|---|
[The effect of pyridinolcarbamate (parmidine) on the microcirculation and immunity of patients with stable angina].
Topics: Angina Pectoris; Antibody Formation; Autoimmunity; Drug Evaluation; Drug Therapy, Combination; Human | 1993 |
Pyridinolcarbamate in the long-term treatment of ischaemic heart disease.
Topics: Aged; Angina Pectoris; Carbamates; Female; Humans; Male; Middle Aged; Pyridinolcarbamate; Time Facto | 1976 |